| scholarly article | Q13442814 |
| P50 | author | Luigi Ferrucci | Q28050062 |
| P2093 | author name string | Melpomeni Peppa | |
| Helen Vlassara | |||
| Weijing Cai | |||
| Jaime Uribarri | |||
| Gary Striker | |||
| Susan Goodman | |||
| P2860 | cites work | Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy | Q24682750 |
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Oxidants, oxidative stress and the biology of ageing | Q28131725 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes | Q28260324 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| Protein glycation, diabetes, and aging | Q32120059 | ||
| Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts | Q33865328 | ||
| Glycoxidation and lipoxidation in atherogenesis | Q34006261 | ||
| Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? | Q34105474 | ||
| Protein oxidation and aging | Q34243989 | ||
| Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond | Q34282992 | ||
| Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy | Q34388076 | ||
| Assessing kidney function--measured and estimated glomerular filtration rate | Q34535861 | ||
| Advanced glycoxidation end products in commonly consumed foods | Q34549688 | ||
| Advanced glycation end products: sparking the development of diabetic vascular injury | Q34555042 | ||
| Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring | Q35594333 | ||
| Isoprostanes: novel bioactive products of lipid peroxidation | Q35754084 | ||
| Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction | Q36088078 | ||
| Overview: renal physiology and pathophysiology of aging | Q37972279 | ||
| Nutritional and toxicological aspects of the Maillard browning reaction in foods | Q38677408 | ||
| Glycation and oxidation: a role in the pathogenesis of atherosclerosis | Q40876719 | ||
| Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. | Q43565214 | ||
| High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study | Q43985739 | ||
| Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. | Q44043194 | ||
| Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients | Q44321459 | ||
| Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study | Q44342232 | ||
| Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice | Q44453007 | ||
| Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice | Q44631836 | ||
| Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study | Q44676231 | ||
| High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients | Q44975110 | ||
| Genetic and environmental effects on fasting and postchallenge plasma glucose and serum insulin values in Finnish twins | Q45280528 | ||
| Historical perspective of the Maillard reaction in food science | Q46613054 | ||
| Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake | Q46620647 | ||
| Glycoxidation and inflammation in renal failure patients | Q47887980 | ||
| NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. | Q50920620 | ||
| Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice | Q56971868 | ||
| Immunochemical detection of advanced glycosylation end products in vivo | Q67895447 | ||
| Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus | Q71940790 | ||
| Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products | Q74450189 | ||
| Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration | Q77795089 | ||
| Role of oxidative stress in diabetic complications: a new perspective on an old paradigm | Q77804864 | ||
| Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity | Q81272522 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 427-33 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | The Journals of Gerontology | Q7743644 |
| P1476 | title | Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging | |
| P478 | volume | 62 |
| Q33854460 | A Perspective on Reagent Diversity and Non-covalent Binding of Reactive Carbonyl Species (RCS) and Effector Reagents in Non-enzymatic Glycation (NEG): Mechanistic Considerations and Implications for Future Research |
| Q97880172 | A negative association of dietary advanced glycation end products with obesity and body composition in Iranian adults |
| Q52873877 | A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women. |
| Q38847549 | A synopsis on aging-Theories, mechanisms and future prospects |
| Q37003623 | AGE restriction in diabetes mellitus: a paradigm shift |
| Q48129676 | AGE-induced neuronal cell death is enhanced in G2019S LRRK2 mutation with increased RAGE expression. |
| Q38116590 | AGEs, contributors to placental bed vascular changes leading to preeclampsia |
| Q39313922 | AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease |
| Q38785141 | Actein protects against methylglyoxal-induced oxidative damage in osteoblastic MC3T3-E1 cells |
| Q64272129 | Administration of Iranian Propolis attenuates oxidative stress and blood glucose in type II diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial |
| Q91640927 | Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects |
| Q38254631 | Advanced Glycation End Products, Inflammation, and Chronic Metabolic Diseases: Links in a Chain? |
| Q26774333 | Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS? |
| Q38647079 | Advanced glycation End-products (AGEs): an emerging concern for processed food industries |
| Q44635769 | Advanced glycation end product homeostasis: exogenous oxidants and innate defenses |
| Q37362121 | Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia |
| Q37520014 | Advanced glycation end products (AGE) and diabetes: cause, effect, or both? |
| Q52655887 | Advanced glycation end products alter steroidogenic gene expression by granulosa cells: an effect partially reversible by vitamin D. |
| Q35255473 | Advanced glycation end products and oxidative stress in type 2 diabetes mellitus |
| Q92408996 | Advanced glycation end products and risk of general and abdominal obesity in Iranian adults: Tehran lipid and glucose study |
| Q55433171 | Advanced glycation end products and risk of hypertension in Iranian adults: Tehran lipid and glucose study. |
| Q34981419 | Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women |
| Q58110046 | Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention |
| Q41836455 | Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial |
| Q24602482 | Advanced glycation end products in foods and a practical guide to their reduction in the diet |
| Q42871314 | Advanced glycation end products induce T cell apoptosis: Involvement of oxidative stress, caspase and the mitochondrial pathway |
| Q36130015 | Advanced glycation end products measured by skin autofluorescence in a population with central obesity |
| Q35093747 | Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer |
| Q36643573 | Advanced glycation end products: Key players in skin aging? |
| Q36979367 | Advanced glycation end-products in senile diabetic and non-diabetic patients with cardiovascular complications |
| Q38118993 | Advanced glycation end-products: a common pathway in diabetes and age-related erectile dysfunction |
| Q26800114 | Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance |
| Q39799183 | Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress |
| Q34217710 | Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults |
| Q36997980 | Advanced glycosylation end products and nutrition--a possible relation with diabetic atherosclerosis and how to prevent it. |
| Q34545820 | Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans |
| Q46082237 | Alagebrium chloride protects the heart against oxidative stress in aging rats |
| Q42528817 | An Ironic Tragedy: Are Spouses of Persons with Dementia at Higher Risk for Dementia than Spouses of Persons without Dementia? |
| Q34056517 | Anti-aging data and support claims--consensus statement |
| Q38025979 | Anti-inflammatory therapy in type 1 diabetes |
| Q46325837 | Antiglycation and anti-oxidant efficiency of carnosine in the plasma and liver of aged rats |
| Q51112090 | Antioxidant balance and accumulation of advanced glycation end products after the consumption of standard diets including Maillard reaction products from silver carp peptides. |
| Q51531853 | Antioxidant diet, gender and age affect renal expression of nitric oxide synthases in obese diabetic rats |
| Q28543766 | Assessment of the concentrations of various advanced glycation end-products in beverages and foods that are commonly consumed in Japan |
| Q35644178 | Association between Advanced Glycation End Products and Impaired Fasting Glucose: Results from the SALIA Study |
| Q36072595 | Association between age-related decline of kidney function and plasma malondialdehyde |
| Q60922998 | Association of Dietary Advanced Glycation End Products with Metabolic Syndrome in Young Mexican Adults |
| Q45004079 | Association of the glycoxidative stress marker pentosidine with equine laminitis. |
| Q28487790 | Biodistribution and elimination study of fluorine-18 labeled Nε-carboxymethyl-lysine following intragastric and intravenous administration |
| Q43097003 | Carbonyl compounds methylglyoxal and glyoxal affect interleukin-8 secretion in intestinal cells by superoxide anion generation and activation of MAPK p38. |
| Q37225026 | Carbonyl stress in aging process: role of vitamins and phytochemicals as redox regulators |
| Q36746679 | Carbonyl stress induces hypertension and cardio-renal vascular injury in Dahl salt-sensitive rats |
| Q37056383 | Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study |
| Q37130258 | Consumption of deep-fried foods and risk of prostate cancer |
| Q37133379 | Could glucose be a proaging factor? |
| Q90720617 | Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products |
| Q26861308 | Development of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end products |
| Q37072018 | Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent? |
| Q40066247 | Dicarbonyl-mediated protein modifications affect matrix metalloproteinase (MMP) activity |
| Q39427655 | Dietary Advanced Glycation End Products and Cardiometabolic Risk |
| Q33616732 | Dietary Metabolites and Chronic Kidney Disease |
| Q35670859 | Dietary advanced glycation end products and aging |
| Q89876552 | Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study |
| Q42519686 | Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus |
| Q60301079 | Dietary advanced glycation end-product consumption leads to mechanical stiffening of murine intervertebral discs |
| Q38077658 | Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review. |
| Q92050647 | Dietary and Plasma Carboxymethyl Lysine and Tumor Necrosis Factor-α as Mediators of Body Mass Index and Waist Circumference among Women in Indonesia |
| Q34706565 | Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study |
| Q40018926 | Dietary consumption of advanced glycation end products and risk of metabolic syndrome |
| Q36364486 | Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study |
| Q31157315 | Dietary interventions to contrast the onset and progression of diabetic nephropathy: A critical survey of new data. |
| Q44474699 | Digestibility of extruded proteins and metabolic transit of N ε -carboxymethyllysine in rats. |
| Q43218267 | Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. |
| Q34531584 | Disulfide bonds within the C2 domain of RAGE play key roles in its dimerization and biogenesis |
| Q24471760 | Do advanced glycation end-products play a role in malaria susceptibility? |
| Q52150433 | Early Diagnosis of Diabetes through the Eye. |
| Q38250741 | Effect of advanced glycation end product intake on inflammation and aging: a systematic review. |
| Q38588208 | Effect of diet-derived advanced glycation end products on inflammation. |
| Q55079458 | Effects of a Low Advanced Glycation End Products Diet on Insulin Levels: The Feasibility of a Crossover Comparison Test. |
| Q46259674 | Effects of bergenin on methylglyoxal-induced damage in osteoblastic MC3T3-E1 cells. |
| Q48205319 | Effects of edible bird's nest on hippocampal and cortical neurodegeneration in ovariectomized rats |
| Q35995060 | Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease |
| Q36220872 | Elevated Serum Carboxymethyl-Lysine, an Advanced Glycation End Product, Predicts Severe Walking Disability in Older Women: The Women's Health and Aging Study I |
| Q37300130 | Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women |
| Q34747124 | Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation |
| Q41964977 | Energy metabolism, altered proteins, sirtuins and ageing: converging mechanisms? |
| Q35173430 | Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults |
| Q42455775 | Food derived carbonyl compounds affect basal and stimulated secretion of interleukin-6 and -8 in Caco-2 cells |
| Q36179583 | Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury |
| Q51765742 | Gingival RAGE expression in calorie-restricted versus ad libitum-fed rats. |
| Q37859317 | Glucose metabolism disorders and the risk of cancer. |
| Q57051319 | Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging |
| Q39096507 | Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis |
| Q36839941 | Glycotoxins in the diet promote diabetes and diabetic complications |
| Q38221639 | Glycoxidation of biological macromolecules: a critical approach to halt the menace of glycation. |
| Q35679515 | Glyoxalase I retards renal senescence |
| Q37800425 | Health effects of dietary Maillard reaction products: the results of ICARE and other studies. |
| Q64264027 | Heterogeneity of Metabolic Defects in Type 2 Diabetes and Its Relation to Reactive Oxygen Species and Alterations in Beta-Cell Mass |
| Q58696156 | Identification of Antiglycative Compounds in Japanese Red Water Pepper (Red Leaf Variant of the Sprout) |
| Q37214116 | Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons |
| Q57110548 | Immunomodulation by Processed Animal Feed: The Role of Maillard Reaction Products and Advanced Glycation End-Products (AGEs) |
| Q39368611 | Impact of Non-Enzymatic Glycation in Neurodegenerative Diseases: Role of Natural Products in Prevention. |
| Q50025272 | Impact of consumption of repeatedly heated cooking oils on the incidence of various cancers- A critical review |
| Q58775747 | Improved Methods for the Rapid Formation and Prevention of Advanced Glycation End Products (AGEs) In Vitro by Coupling to the Hypoxanthine/Xanthine Oxidase Assay System |
| Q38901241 | In vivo imaging of advanced glycation end products (AGEs) of albumin: first observations of significantly reduced clearance and liver deposition properties in mice |
| Q50103611 | Inhibiting Effect of Zinc Oxide Nanoparticles on Advanced Glycation Products and Oxidative Modifications: a Potential Tool to Counteract Oxidative Stress in Neurodegenerative Diseases |
| Q36080001 | Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice |
| Q34983879 | Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products |
| Q38563967 | Inhibitory effects and actions of pentacyclic triterpenes upon glycation |
| Q26740443 | Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders |
| Q90150241 | Intake of dietary advanced glycation end products influences inflammatory markers, immune phenotypes, and antiradical capacity of healthy elderly in a little-studied population |
| Q47271148 | Interaction between environment, nutrient-derived metabolites and immunity: A possible role in malaria susceptibility/resistance in Fulani and Dogon of Mali |
| Q51368824 | Intramuscular injection of soluble receptor for advanced glycation endproducts expression vector prevents the development of streptozotocin-induced diabetes mellitus in rats on high fat diet. |
| Q93052433 | Ketogenic diets: Boon or bane? |
| Q28079797 | Klotho: a humeral mediator in CSF and plasma that influences longevity and susceptibility to multiple complex disorders, including depression |
| Q33680171 | Lifestyle and Advanced Glycation End Products (AGEs) Burden: Its Relevance to Healthy Aging |
| Q26795694 | Linking RAGE and Nox in diabetic micro- and macrovascular complications |
| Q36796216 | Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift |
| Q34153508 | Maternally transmitted and food-derived glycotoxins: a factor preconditioning the young to diabetes? |
| Q33633674 | Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease |
| Q57131309 | Mechanistic targeting of advanced glycation end-products in age-related diseases |
| Q52891782 | Mediterranean Diet Supplemented With Coenzyme Q10 Modulates the Postprandial Metabolism of Advanced Glycation End Products in Elderly Men and Women. |
| Q37214275 | Metabolic syndrome and physical decline in older persons: results from the Health, Aging And Body Composition Study |
| Q43968558 | Metabolic transit of N(ε)-carboxymethyl-lysine after consumption of AGEs from bread crust |
| Q48178370 | Methylglyoxal-induced cytotoxicity in neonatal rat brain: a role for oxidative stress and MAP kinases |
| Q26739495 | Microglial Priming and Alzheimer's Disease: A Possible Role for (Early) Immune Challenges and Epigenetics? |
| Q27014620 | Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets |
| Q43595134 | N-ε-fructosyllysine and N-ε-carboxymethyllysine, but not lysinoalanine, are available for absorption after simulated gastrointestinal digestion |
| Q38791329 | New and old mechanisms associated with hypertension in the elderly. |
| Q33699731 | Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus |
| Q37729841 | Nutrients and the Pancreas: An Epigenetic Perspective |
| Q37607470 | Nutrition and AGE-ing: Focusing on Alzheimer's Disease. |
| Q36300685 | Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. |
| Q36778201 | Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan |
| Q36323182 | Oxidant stress and mitochondrial signaling regulate reversible changes of ERα expression and apoptosis in aging mouse glomeruli and mesangial cells |
| Q37731347 | Oxidative stress and aging: is methylglyoxal the hidden enemy? |
| Q34452521 | Oxidative stress as a mechanism of added sugar-induced cardiovascular disease |
| Q48199124 | Pathophysiology and therapeutics of premature ageing in chronic kidney disease, with a focus on glycative stress. |
| Q47575059 | Perinatal exposure to high dietary advanced glycation end products in transgenic NOD8.3 mice leads to pancreatic beta cell dysfunction. |
| Q43102878 | Phosphate and CVD: it's all in what's on the table |
| Q37445850 | Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults |
| Q38358965 | Prevention of protein glycation by natural compounds. |
| Q37641659 | Processed meat consumption and lung function: modification by antioxidants and smoking |
| Q30318385 | Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma. |
| Q37417494 | Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1. |
| Q58701396 | Proteomic and immunochemical approaches to understanding the glycation behaviour of the casein and β-lactoglobulin fractions of flavoured drinks under UHT processing conditions |
| Q37860348 | RAGE biology, atherosclerosis and diabetes |
| Q33346824 | RAGE signaling in inflammation and arterial aging |
| Q59075718 | Reactive carbonyl species in vivo: generation and dual biological effects |
| Q35855642 | Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression |
| Q36047141 | Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women |
| Q36212513 | Relationship of a dominant advanced glycation end product, serum carboxymethyl-lysine, and abnormal glucose metabolism in adults: The baltimore longitudinal study of aging |
| Q33603990 | Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study |
| Q58577346 | Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies |
| Q91591370 | Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies |
| Q37641049 | Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging |
| Q46126412 | Serum advanced glycation end products (AGEs) are associated with insulin resistance |
| Q35690158 | Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults |
| Q30578167 | Serum carboxymethyl-lysine, disability, and frailty in older persons: the Cardiovascular Health Study |
| Q51553376 | Serum levels of advanced glycation end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects. |
| Q37192036 | Sexual dimorphism of the aging kidney: role of nitric oxide deficiency |
| Q48708732 | Systemic effects of AGEs in ER stress induction in vivo |
| Q26767495 | The Contribution of Advanced Glycation End product (AGE) accumulation to the decline in motor function |
| Q42226832 | The Protective Effect of Antioxidants Consumption on Diabetes and Vascular Complications |
| Q34012904 | The human tri-peptide GHK and tissue remodeling |
| Q36670537 | The molecular basis of peanut allergy |
| Q59336758 | The poly-omics of ageing through individual-based metabolic modelling |
| Q43899522 | The relationship between dietary advanced glycation end products and indicators of diabetes severity in Mexicans and non-Hispanic whites: a pilot study |
| Q38896877 | Traditional and emerging indicators of cardiovascular risk in chronic obstructive pulmonary disease. |
| Q92635133 | UV Fluorescence-Based Determination of Urinary Advanced Glycation End Products in Patients with Chronic Kidney Disease |
| Q50938013 | Urinary excretion of dietary Maillard reaction products in healthy adult female cats. |
| Q92823941 | Use of Grape Pomace Phenolics to Counteract Endogenous and Exogenous Formation of Advanced Glycation End-Products |
Search more.